Tag: Cancer: Prostate
ASCO: Abiraterone Extends Survival in Metastatic Prostate CA
Side effects noted with use of abiraterone similar to those already found in patients taking the drug
Substantial Increase in Costs With Metastases in Prostate CA
Costs peak during month of metastases diagnosis, reaching $13,291
Combined Urine Test for T2:ERG, PCA3 Ups Prostate CA Detection
Combined urinary testing can avoid unnecessary prostate biopsy, while preserving high sensitivity
Distinct Outcomes for Luminal-, Basal-Like Prostate Cancers
Luminal B prostate cancers exhibited poorest clinical prognosis in univariate, multivariate analyses
Black Men Have Higher Rate of Preclinical Prostate Cancer
Also increased risk of progression to metastatic disease compared with the general population
PSA Screening Rates Have Leveled Off in U.S.
Decline followed recommendations from U.S. Preventive Services Task Force
Surveillance Biopsy Timing Not Tied to Reclassification
But PSA density and body mass index are associated with prostate cancer reclassification
Yoga Helps Ease Side Effects of Prostate Cancer Treatment
Men who attended yoga classes had less fatigue and better sexual and urinary function
PSA Test Often Occurs Without Discussion of Benefits, Harms
Men with lower incomes, education, and no insurance less likely to receive pretest counseling
Metformin Use Does Not Increase Prostate Cancer Survival
Drug given in combination with docetaxel chemotherapy in patients with metastatic disease
